High-risk human papillomavirus cervical infection prevalence: a nationwide retrospective study comparing opportunistic and organised screening, France, 2020 to 2023
BACKGROUND In France, cervical cancer screening for females aged 30–65 years primarily tests for high-risk (HR) human papillomavirus (HPV) infections. AIM We aimed to map the prevalence of cervical infections caused by HPV16 and/or 18, or by any of 12 other carcinogenic HPV genotypes and compare pr...
Saved in:
| Main Author: | Samuel Alizon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Centre for Disease Prevention and Control
2025-07-01
|
| Series: | Eurosurveillance |
| Subjects: | |
| Online Access: | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.28.2400689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bayesian Inference for Long Memory Stochastic Volatility Models
by: Pedro Chaim, et al.
Published: (2024-11-01) -
Human papillomavirus prevalence in first, second and third cervical cell samples from women HPV-vaccinated as girls, Denmark, 2017 to 2024: data from the Trial23 cohort study
by: Elsebeth Lynge
Published: (2025-07-01) -
Prevalence and attributes of cervicovaginal human papillomavirus infection among a 35-year- age- cohort of ever-married women in a district of Sri Lanka: a cross-sectional study
by: K. C. M. Perera, et al.
Published: (2025-07-01) -
Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping
by: Alisa P. Young, et al.
Published: (2025-02-01) -
Prevalence and Description of High‐Grade Intraepithelial Lesions of Cervical Mucosa Cells in a Screening Programme for Cervical Cancer in Isère, France
by: Christian Balamou, et al.
Published: (2024-10-01)